Pharmaceutical Drugs are widely used for treating a multitude of diseases like cough, cold, diabetes, cancer, HIV, headache, viral fever, nausea, typhoid, tuberculosis, tumor, heart attack, hyper tension, depression, etc.
Enbrel has a boxed warning in its package insert noting an increased risk of cancer malignancies, tuberculosis, reactivation of tuberculosis, and other opportunistic infections associated with its use.
RECOMMENDATIONS FOR SCREENING FOR TUBERCULOSIS (TB) IN PATIENTS GIVEN BIOLOGICS OR XELJANZ, RECOMMENDATIONS FOR VACCINATIONS IN PATIENTS RECEIVING DMARDS OR BIOLOGICS, AS WELL AS RECOMMENDATIONS FOR THE LABORATORY MONITORING OF TRADITIONAL DMARDS ARE ALSO OF NOTE.
Alongside their wide range of medical uses, there are side effects, such as, cancer, tuberculosis, fungal infections and other opportunistic infections that are caused due to prolonged use of these drugs.
533 pages •
By Roots Analysis Private Ltd.
• Dec 2016
No. ## Product Name TUBERCULOSIS RECOMBINANT SUBUNIT VACCINE V## (PNEUMOCONJUGATE-## VACCINE) NDV-## Company SANOFI ## ## Indication TUBERCULOSIS PNEUMOCOCCAL INFECTIONS STAPHYLOCOCCAL INFECTIONS, CANDIDIASIS MERCK NOVADIGM THERAPEUTICS IM IM Phase of Development PHASE II RoA IM PH
It undertakes extensive research and development of pharmaceuticals for treatment of migraine, gastrointestinal, psoriasis, central nervous system, cardiovascular, tuberculosis, diabetes and inflammation.
The company undertakes extensive research and development of pharmaceuticals for treatment of migraine, gastrointestinal, psoriasis, central nervous system, cardiovascular, tuberculosis, diabetes and inflammation.
Aug 30, 2016: FDA approves Erelzi, a biosimilar to Enbrel
Erelzi contains a Boxed Warning to alert health care professionals and patients about an increased risk of serious infections leading to hospitalization or death, including tuberculosis, invasive fungal infections (such as histoplasmosis) and others.
TUBERCULOSIS (TB) FUNGAL MALARIA VIRAL COMMON COLD CYTOMEGALOVIRUS EBOLA B C HERPES SIMPLEX HIV INFLUENZA POLIO RESPIRATORY SYNCYTIAL VIRUS (RSV) ZIKA METABOLIC DIABETES DATE PARTIES STAGE VALUE US$M SUBJECT CONTRACT MEDICINES JOINT VENTURE AGREEMENT FOR COMMERCIALIZATION OF SEP 2016 NEMAUR